Physician profile
James Stokes
NPI 1952490351
$1,452.97
in general payments reported to CMS, 2019-2025
17 companies · $821 in 2025
The $821 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.94 · 2020: $33.09 · 2021: $93.49 · 2022: $127 · 2023: $64.61 · 2024: $245 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $750 · Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $750.00 |
| Food and Beverage | $380.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $903.48 | 2020-2025 | |
| Becton, Dickinson and Company | $88.84 | 2024 | |
| Smith+Nephew, INC. | $87.97 | 2019-2024 | Stravix, Collagenase Santyl |
| Heron Therapeutics, INC. | $56.24 | 2022 | |
| Tela Bio, INC. | $44.27 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $39.00 | 2022-2024 | Interstim |
| Osiris Therapeutics INC. | $32.97 | 2019 | |
| Merit Medical Systems INC | $30.11 | 2024-2025 | Savi Scout |
| Axonics, INC. | $29.09 | 2024 | Bulkamid, Axonics |
| Takeda Pharmaceuticals U.S.A., INC. | $27.39 | 2023 | Gattex |
| Abbvie INC. | $22.20 | 2023 | Dalvance |
| Polynovo North America LLC | $22.14 | 2024 | Novosorb Btm |
| Emd Serono, INC. | $16.19 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.26 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $15.02 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $14.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Thd America, INC. | $8.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.